Perceived stress predicts the stability of vitamin K-antagonist treatment of anticoagulant clinic patients.
Jane
J
Skov
Anja
A
Leppin
Else-Marie
EM
Bladbjerg
Johannes J
JJ
Sidelmann
Jørgen
J
Gram
D000368:Aged; D000925:Anticoagulants / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D001281:Atrial Fibrillation / Q000097:blood / Q000523:psychology; D015897:Comorbidity; D065729:Cytochrome P-450 CYP2C9; D003718:Denmark / Q000453:epidemiology; D016903:Drug Monitoring; D005260:Female; D005838:Genotype; D006801:Humans; D019934:International Normalized Ratio; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D010044:Outpatient Clinics, Hospital / Q000706:statistics & numerical data; D010644:Phenprocoumon / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011446:Prospective Studies; D012720:Severity of Illness Index; D013315:Stress, Psychological / Q000097:blood*; D011795:Surveys and Questionnaires; D019851:Thrombophilia / Q000097:blood / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D010644:Phenprocoumon